Jin Yang Pharmaceutical Co. Ltd (007370) — Cash Flow Quality Index
Jin Yang Pharmaceutical Co. Ltd (007370) has a Cash Flow Quality Index of -0.18x as of December 2025. Operating cash flow of ₩-3.47 Billion is below net income of ₩19.33 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore investment intensity of Jin Yang Pharmaceutical Co. Ltd to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jin Yang Pharmaceutical Co. Ltd Cash Flow Quality Index (2014–2025)
Historical Cash Flow Quality Index for Jin Yang Pharmaceutical Co. Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of Jin Yang Pharmaceutical Co. Ltd to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Jin Yang Pharmaceutical Co. Ltd (2014–2025)
Year-by-year earnings quality comparison for Jin Yang Pharmaceutical Co. Ltd. For live market cap and the full company financial profile, see Jin Yang Pharmaceutical Co. Ltd (007370) total market value.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.07x | ₩1.46 Billion | ₩22.29 Billion | ▼ -84.7% |
| 2024 | 0.43x | ₩12.79 Billion | ₩29.69 Billion | ▼ -36.1% |
| 2023 | 0.67x | ₩8.53 Billion | ₩12.66 Billion | ▲ +11.4% |
| 2022 | 0.61x | ₩7.45 Billion | ₩12.31 Billion | ▲ +192.9% |
| 2021 | 0.21x | ₩1.97 Billion | ₩9.54 Billion | ▼ -87.8% |
| 2020 | 1.70x | ₩6.24 Billion | ₩3.68 Billion | ▼ -61.2% |
| 2019 | 4.38x | ₩7.21 Billion | ₩1.65 Billion | ▲ +285.9% |
| 2018 | 1.13x | ₩1.06 Billion | ₩933.15 Million | ▲ +247.7% |
| 2014 | -0.77x | ₩-3.08 Billion | ₩4.01 Billion | — |